Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart McPherson

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 3: special circumstancesDina Mansour, Steven Masson, John Hammond, et al.
Journal of Hepatology|February 16, 2019
The degree of hepatic steatosis associates with impaired cardiac and autonomic functionDavid Houghton, Paweł Zalewski, Kate Hallsworth, et al.
Journal of Viral Hepatitis|October 19, 2020
Persistent Hepatitis E virus infection across England and Wales 2009-2017: Demography, virology and outcomesMichael Ankcorn, Bengü Said, Dilys Morgan, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.
Frontline Gastroenterology|December 17, 2021
Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver diseaseLaura Jane Neilson, Louise Macdougall, Phey Shen Lee, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2022
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' replyDanielle Brandman, Marie Boyle, Stuart McPherson, et al.
Gastroenterology|February 7, 2020
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisRod S Taylor, Rebecca J Taylor, Sue Bayliss, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 1: compensated cirrhosisDina Mansour, Steven Masson, Debbie L Shawcross, et al.
Plos One|January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virusAminata Sy, Leanne McCabe, Emma Hudson, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 3: special circumstancesDina Mansour, Steven Masson, John Hammond, et al.
Journal of Hepatology|February 16, 2019
The degree of hepatic steatosis associates with impaired cardiac and autonomic functionDavid Houghton, Paweł Zalewski, Kate Hallsworth, et al.
Journal of Viral Hepatitis|October 19, 2020
Persistent Hepatitis E virus infection across England and Wales 2009-2017: Demography, virology and outcomesMichael Ankcorn, Bengü Said, Dilys Morgan, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.
Frontline Gastroenterology|December 17, 2021
Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver diseaseLaura Jane Neilson, Louise Macdougall, Phey Shen Lee, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2022
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' replyDanielle Brandman, Marie Boyle, Stuart McPherson, et al.
Gastroenterology|February 7, 2020
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisRod S Taylor, Rebecca J Taylor, Sue Bayliss, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 1: compensated cirrhosisDina Mansour, Steven Masson, Debbie L Shawcross, et al.
Plos One|January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virusAminata Sy, Leanne McCabe, Emma Hudson, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Pageof 11